Background: This study was to elucidate the impact of blast-induced neurotrauma (BINT) on phosphoproteome networks and cognition in a genetically heterogeneous population of mice (rTg4510) with the human tau P301L mutation linked to Alzheimer's disease-related dementia (ADRD) including frontotemporal dementia.

Method: Mild traumatic brain injury was induced in rTg4510 mice exposed to a single low-density blast (LIB) at an upright position. After assessment of cognitive function by the automated-Home Cage Monitoring (aHCM) system, frontal cortex tissue was collected at 40 days post-injury. The label-free tandem mass spectrometry using the data-independent acquisition and parallel accumulation-serial fragmentation techniques for quantitative proteomics and weighted peptide co-expression-network analysis (WpCNA) approaches were used to evaluate phosphoproteomes in association with synaptic function and learning ability.

Result: In this study, blast-exposed rTg4510 mice demonstrated a lower learning index, using the CognitionWall test by aHCM, compared to all other groups including non-carrier unexposed sham controls. Among total 17,637 phosphopeptides identified, 706 and 550 were significantly changed in rTg4510 and non-carrier LIB-exposed mice relative to unexposed sham controls, respectively. Using WpCNA, we found phosphopeptide networks tied to associative learning and mossy-fiber pathways, which predicted learning outcomes. Phosphopeptide expression in these networks were inversely related to learning and linked to synaptic dysfunction, cognitive decline, and dementia. LIB selectively increased pSer262 Tau in rTg4510, a site implicated in initiating tauopathy.

Conclusion: This study unveils the relationship between ADRD genetic susceptibility, BINT, and cognitive decline, thus offering potential pathways as therapeutic targets for precision medicine to alleviate the disease burden among those affected by BINT.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.084781DOI Listing

Publication Analysis

Top Keywords

rtg4510 mice
8
unexposed sham
8
sham controls
8
cognitive decline
8
rtg4510
5
learning
5
basic science
4
science pathogenesis
4
pathogenesis background
4
background study
4

Similar Publications

Background: Progressive supranuclear palsy (PSP) is a devastating primary tauopathy with rapid progression to death. Although several therapies currently in the development pipeline show promising safety profiles and robust target engagement, few demonstrated significant efficacy in patients, underscoring the need to interrogate additional targets with novel therapeutic modalities to expand the potential therapeutic arsenal. To diversify the therapeutic avenues for PSP and related tauopathies (e.

View Article and Find Full Text PDF

Background: This study was to elucidate the impact of blast-induced neurotrauma (BINT) on phosphoproteome networks and cognition in a genetically heterogeneous population of mice (rTg4510) with the human tau P301L mutation linked to Alzheimer's disease-related dementia (ADRD) including frontotemporal dementia.

Method: Mild traumatic brain injury was induced in rTg4510 mice exposed to a single low-density blast (LIB) at an upright position. After assessment of cognitive function by the automated-Home Cage Monitoring (aHCM) system, frontal cortex tissue was collected at 40 days post-injury.

View Article and Find Full Text PDF
Article Synopsis
  • People with Alzheimer's disease experience early mood, sleep, and arousal changes due to brain changes, especially in the dorsal raphe nucleus (DRN), but it’s unclear why all serotonin-producing neurons are not equally affected.
  • The study aimed to explore genetic factors that influence how susceptible or resistant these serotonin neurons are to Alzheimer's disease pathology using advanced spatial gene expression analysis in a mouse model.
  • The results showed that specific genes related to AD are differently expressed in the DRN of these mice, and that the loss of serotonin neurons and tau pathology is particularly pronounced in a specific region of the DRN, highlighting the importance of studying genetic and regulatory factors in Alzheimer's.
View Article and Find Full Text PDF
Article Synopsis
  • Metabolic disorders like diabetes and obesity are connected to neurodegenerative diseases, showing reduced brain glucose metabolism and insulin resistance in dementia patients.
  • A study on mice with tauopathy assessed the effects of an 8-week dietary methionine restriction (MR) on behavior and metabolism, particularly focusing on older mice (12 months).
  • Results showed that MR significantly improved motor skills, short-term memory, and social recognition in older mice, linked to increased markers of glycolysis and FGF21R1 levels in the brain, indicating potential therapeutic benefits for tau-related conditions.
View Article and Find Full Text PDF

Development of a novel radioiodinated compound for amyloid and tau deposition imaging in Alzheimer's disease and tauopathy mouse models.

Neuroimage

December 2024

Department of Radiopharmacy and Molecular Imaging, Minhang Hospital & School of Pharmacy, Fudan University, Shanghai, China; Department of Functional Brain Imaging Research, China; Department of Clinical and Experimental Neuroimaging, Centre for Development of Advanced Medicine for Dementia, National Centre for Geriatrics and Gerontology, Obu, Japan; Key Laboratory of Smart Drug Delivery, Fudan University, Ministry of Education, Shanghai, China; Institute for Small-Molecule Drug Discovery & Development, Quzhou Fudan Institute, Quzhou, China. Electronic address:

Article Synopsis
  • - The study focused on a new compound called AD-DRK (I-AD-DRK) that can non-invasively identify amyloid-β and tau deposits in the brain, which are critical for diagnosing Alzheimer's disease and related disorders.
  • - Researchers conducted tests using this compound in both postmortem human brains and mouse models with amyloid and tau accumulation, demonstrating its effective binding and visualization capabilities in the brain regions associated with these proteins.
  • - The results showed that I-AD-DRK has strong potential as a SPECT imaging agent, offering high-contrast imaging of amyloid and tau, which could significantly help in early diagnosis and treatment of Alzheimer's disease and other tauopathies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!